[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Dermatology Drug Industry 2016 Market Research Report

May 2016 | 131 pages | ID: UCB40C62550EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Dermatology Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Dermatology Drug industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Dermatology Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Dermatology Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 147 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 INDUSTRY OVERVIEW

1.1 Definition and Specifications of Dermatology Drug
1.2 Classification of Dermatology Drug
1.3 Applications of Dermatology Drug
1.4 Industry Chain Structure of Dermatology Drug
1.5 Industry Overview of Dermatology Drug
1.6 Industry Policy Analysis of Dermatology Drug
1.7 Industry News Analysis of Dermatology Drug

2 MANUFACTURING COST STRUCTURE ANALYSIS OF DERMATOLOGY DRUG

2.1 Bill of Materials (BOM) of Dermatology Drug
2.2 BOM Price Analysis of Dermatology Drug
2.3 Labor Cost Analysis of Dermatology Drug
2.4 Depreciation Cost Analysis of Dermatology Drug
2.5 Manufacturing Cost Structure Analysis of Dermatology Drug
2.6 Manufacturing Process Analysis of Dermatology Drug
2.7 United States Price, Cost and Gross of Dermatology Drug 2011-2016

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Dermatology Drug Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Dermatology Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Dermatology Drug Key Manufacturers in 2015

4 PRODUCTION ANALYSIS OF DERMATOLOGY DRUG BY REGIONS, TYPE, AND APPLICATIONS

4.1 United States Production of Dermatology Drug by Regions 2011-2016
4.2 United States Production of Dermatology Drug by Type 2011-2016
4.3 United States Sales of Dermatology Drug by Applications 2011-2016
4.4 Price Analysis of United States Dermatology Drug Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Dermatology Drug 2011-2016

5 CONSUMPTION VOLUME AND CONSUMPTION VALUE ANALYSIS OF DERMATOLOGY DRUG BY REGIONS

5.1 United States Consumption Volume of Dermatology Drug by Regions 2011-2016
5.2 United States Consumption Value of Dermatology Drug by Regions 2011-2016
5.3 United States Consumption Price Analysis of Dermatology Drug by Regions 2011-2016

6 ANALYSIS OF DERMATOLOGY DRUG PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Dermatology Drug 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Dermatology Drug 2014-2015
6.3 Sales Overview of Dermatology Drug 2011-2016
6.4 Supply, Consumption and Gap of Dermatology Drug 2011-2016
6.5 Import, Export and Consumption of Dermatology Drug 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Dermatology Drug 2011-2016

7 ANALYSIS OF DERMATOLOGY DRUG INDUSTRY KEY MANUFACTURERS

7.1 Novartis
  7.1.1 Company Profile
  7.1.2 Product Picture and Specification
  7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.1.4 Novartis SWOT Analysis
7.2 Roche
  7.2.1 Company Profile
  7.2.2 Product Picture and Specification
  7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.2.4 Roche SWOT Analysis
7.3 Pfizer
  7.3.1 Company Profile
  7.3.2 Product Picture and Specification
  7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.3.4 Pfizer SWOT Analysis
7.4 MSD
  7.4.1 Company Profile
  7.4.2 Product Picture and Specification
  7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.4.4 MSD SWOT Analysis
7.5 Sinofi
  7.5.1 Company Profile
  7.5.2 Product Picture and Specification
  7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.5.4 Sinofi SWOT Analysis
7.6 GSK
  7.6.1 Company Profile
  7.6.2 Product Picture and Specification
  7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.6.4 GSK SWOT Analysis
7.7 Johnson&Johnson
  7.7.1 Company Profile
  7.7.2 Product Picture and Specification
  7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.7.4 Johnson&Johnson SWOT Analysis
7.8 AstraZeneca
  7.8.1 Company Profile
  7.8.2 Product Picture and Specification
  7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.8.4 AstraZeneca SWOT Analysis
7.9 Amgen
  7.9.1 Company Profile
  7.9.2 Product Picture and Specification
  7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.9.4 Amgen SWOT Analysis
7.10 AbbVie
  7.10.1 Company Profile
  7.10.2 Product Picture and Specification
  7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.10.4 AbbVie SWOT Analysis

8 PRICE AND GROSS MARGIN ANALYSIS

8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Dermatology Drug Product Types
8.5 Market Share Analysis of Different Dermatology Drug Price Levels
8.6 Gross Margin Analysis of Different Dermatology Drug Applications

9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF DERMATOLOGY DRUG

9.1 Marketing Channels Status of Dermatology Drug
9.2 Traders or Distributors of Dermatology Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Dermatology Drug
9.4 United States Import, Export and Trade Analysis of Dermatology Drug

10 DEVELOPMENT TREND OF DERMATOLOGY DRUG INDUSTRY 2016-2021

10.1 Capacity and Production Overview of Dermatology Drug 2016-2021
10.2 Production Market Share by Product Types of Dermatology Drug 2016-2021
10.3 Sales and Sales Revenue Overview of Dermatology Drug 2016-2021
10.4 United States Sales of Dermatology Drug by Applications 2016-2021
10.5 Import, Export and Consumption of Dermatology Drug 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Dermatology Drug 2016-2021

11 INDUSTRY CHAIN SUPPLIERS OF DERMATOLOGY DRUG WITH CONTACT INFORMATION

11.1 Major Raw Materials Suppliers of Dermatology Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Dermatology Drug with Contact Information
11.3 Major Players of Dermatology Drug with Contact Information
11.4 Key Consumers of Dermatology Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Dermatology Drug

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF DERMATOLOGY DRUG

12.1 New Project SWOT Analysis of Dermatology Drug
12.2 New Project Investment Feasibility Analysis of Dermatology Drug

13 CONCLUSION OF THE UNITED STATES DERMATOLOGY DRUG INDUSTRY 2016 MARKET RESEARCH REPORT
LIST OF TABLES AND FIGURES

Figure Picture of Dermatology Drug
Table Product Specifications of Dermatology Drug
Table Classification of Dermatology Drug
Figure United States Sales Market Share of Dermatology Drug by Product Types in 2015
Table Applications of Dermatology Drug
Figure United States Sales Market Share of Dermatology Drug by Applications in 2015
Figure Industry Chain Structure of Dermatology Drug
Table United States Industry Overview of Dermatology Drug
Table Industry Policy of Dermatology Drug
Table Industry News List of Dermatology Drug
Table Bill of Materials (BOM) of Dermatology Drug
Table Bill of Materials (BOM) Price of Dermatology Drug
Table Labor Cost of Dermatology Drug
Table Depreciation Cost of Dermatology Drug
Table Manufacturing Cost Structure Analysis of Dermatology Drug in 2015
Figure Manufacturing Process Analysis of Dermatology Drug
Table United States Price Analysis of Dermatology Drug 2011-2016 (USD/T)
Table United States Cost Analysis of Dermatology Drug 2011-2016 (USD/T)
Table United States Gross Analysis of Dermatology Drug 2011-2016
Table Capacity (K T) and Commercial Production Date of United States Dermatology Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Dermatology Drug Manufacturers in 2015
Table R&D Status and Technology Source of United States Dermatology Drug Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Dermatology Drug Key Manufacturers in 2015
Table United States Production of Dermatology Drug by Regions 2011-2016 (K T)
Table United States Production Market Share of Dermatology Drug by Regions 2011-2016
Figure United States Production Market Share of Dermatology Drug by Regions in 2014
Figure United States Production Market Share of Dermatology Drug by Regions in 2015
Table United States Production of Dermatology Drug by Types in 2011-2016 (K T)
Table United States Production Market Share of Dermatology Drug by Type in 2011-2016
Figure United States Production Market Share of Dermatology Drug by Type in 2014
Figure United States Production Market Share of Dermatology Drug by Type in 2015
Table United States Sales of Dermatology Drug by Applications 2011-2016 (K T)
Table United States Production Market Share of Dermatology Drug by Applications 2011-2016
Figure United States Production Market Share of Dermatology Drug by Applications in 2014
Figure United States Production Market Share of Dermatology Drug by Applications in 2015
Table Price Comparison of United States Dermatology Drug Key Manufacturers in 2015 (USD/T)
Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Dermatology Drug 2011-2016
Table United States Consumption Volume of Dermatology Drug by Regions 2011-2016 (K T)
Table United States Consumption Volume Market Share of Dermatology Drug by Regions 2011-2016
Figure United States Consumption Volume Market Share of Dermatology Drug by Regions in 2014
Figure United States Consumption Volume Market Share of Dermatology Drug by Regions in 2015
Table United States Consumption Value of Dermatology Drug by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Dermatology Drug by Regions 2011-2016
Figure United States Consumption Value Market Share of Dermatology Drug by Regions in 2014
Figure United States Consumption Value Market Share of Dermatology Drug by Regions in 2015
Table Consumption Price of Dermatology Drug by Regions 2011-2016 (USD/T)
Table United States and Major Manufacturers Capacity of Dermatology Drug 2011-2016 (K T)
Table United States Capacity Market Share of Major Dermatology Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Dermatology Drug 2011-2016 (K T)
Table United States Production Market Share of Major Dermatology Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Dermatology Drug 2011-2016 (K T)
Table United States Sales Market Share of Major Dermatology Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Dermatology Drug 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Dermatology Drug Manufacturers 2011-2016
Figure United States Capacity (K T), Production (K T) and Growth Rate of Dermatology Drug 2011-2016
Figure United States Capacity Utilization Rate of Dermatology Drug 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Dermatology Drug 2011-2016
Figure United States Production Market Share of Major Dermatology Drug Manufacturers in 2014
Figure United States Production Market Share of Major Dermatology Drug Manufacturers in 2015
Figure United States Sales Market Share of Major Dermatology Drug Manufacturers in 2014
Figure United States Sales Market Share of Major Dermatology Drug Manufacturers in 2015
Figure United States Sales (K T) and Growth Rate of Dermatology Drug 2011-2016
Table United States Supply, Consumption and Gap of Dermatology Drug 2011-2016 (K T)
Table United States Import, Export and Consumption of Dermatology Drug 2011-2016 (K T)
Table Price of United States Dermatology Drug Major Manufacturers 2011-2016 (USD/T)
Table Gross Margin of United States Dermatology Drug Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Dermatology Drug 2011-2016 (M USD)
Table United States Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Revenue (M USD) and Gross Margin of Dermatology Drug 2011-2016
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of Novartis
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of Novartis 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of Novartis 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of Novartis 2011-2016
Table Novartis Dermatology Drug SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of Roche
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of Roche 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of Roche 2011-2016
Table Roche Dermatology Drug SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of Pfizer
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of Pfizer 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of Pfizer 2011-2016
Table Pfizer Dermatology Drug SWOT Analysis
Table MSD Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of MSD
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of MSD 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of MSD 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of MSD 2011-2016
Table MSD Dermatology Drug SWOT Analysis
Table Sinofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of Sinofi
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of Sinofi 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of Sinofi 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of Sinofi 2011-2016
Table Sinofi Dermatology Drug SWOT Analysis
Table GSK Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of GSK
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of GSK 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of GSK 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of GSK 2011-2016
Table GSK Dermatology Drug SWOT Analysis
Table Johnson&Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of Johnson&Johnson
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of Johnson&Johnson 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of Johnson&Johnson 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of Johnson&Johnson 2011-2016
Table Johnson&Johnson Dermatology Drug SWOT Analysis
Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of AstraZeneca
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of AstraZeneca 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of AstraZeneca 2011-2016
Table AstraZeneca Dermatology Drug SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of Amgen
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of Amgen 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of Amgen 2011-2016
Table Amgen Dermatology Drug SWOT Analysis
Table AbbVie Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Dermatology Drug Picture and Specifications of AbbVie
Table Dermatology Drug Capacity (K T), Production (K T), Price (USD/T), Cost (USD/T), Gross (USD/T), Revenue (M USD) and Gross Margin of AbbVie 2011-2016
Figure Dermatology Drug Capacity (K T), Production (K T) and Growth Rate of AbbVie 2011-2016
Figure Dermatology Drug Production (K T) and United States Market Share of AbbVie 2011-2016
Table AbbVie Dermatology Drug SWOT Analysis
Table Dermatology Drug Price by Regions 2011-2016
Table Dermatology Drug Price by Product Types 2011-2016
Table Dermatology Drug Price by Companies 2011-2016
Table Dermatology Drug Gross Margin by Companies 2011-2016
Table Price Comparison of Dermatology Drug by Regions 2011-2016 (USD/T)
Table Price of Different Dermatology Drug Product Types (USD/T)
Table Market Share of Different Dermatology Drug Price Level
Table Gross Margin of Different Dermatology Drug Applications
Table Marketing Channels Status of Dermatology Drug
Table Traders or Distributors of Dermatology Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Dermatology Drug (USD/T) in 2015
Table United States Import, Export, and Trade of Dermatology Drug (K T)
Figure United States Capacity (K T), Production (K T) and Growth Rate of Dermatology Drug 2016-2021
Figure United States Capacity Utilization Rate of Dermatology Drug 2016-2021
Table United States Dermatology Drug Production by Type 2016-2021 (K T)
Table United States Dermatology Drug Production Market Share by Type 2016-2021
Figure United States Production Market Share of Dermatology Drug by Type in 2021
Figure United States Sales (K T) and Growth Rate of Dermatology Drug 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Dermatology Drug 2016-2021
Figure United States Sales of Dermatology Drug by Applications 2016-2021 (K T)
Table United States Production Market Share of Dermatology Drug by Applications 2016-2021
Figure United States Production Market Share of Dermatology Drug by Applications in 2021
Table United States Production, Import, Export and Consumption of Dermatology Drug 2016-2021 (K T)
Table United States Production (K T), Price (USD/T), Cost (USD/T), Revenue (M USD) and Gross Margin of Dermatology Drug 2016-2021
Table Major Raw Materials Suppliers of Dermatology Drug with Contact Information
Table Manufacturing Equipment Suppliers of Dermatology Drug with Contact Information
Table Major Players of Dermatology Drug with Contact Information
Table Key Consumers of Dermatology Drug with Contact Information
Table Supply Chain Relationship Analysis of Dermatology Drug
Table New Project SWOT Analysis of Dermatology Drug
Table New Project Investment Feasibility Analysis of Dermatology Drug
Table Part of Interviewees Record List


More Publications